The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
Zacks.com on MSN1d
CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's ImfinziJohnson & Johnson JNJ announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use ...
Zacks.com on MSN2d
Biogen Stock Down on Regulatory Update in the EU for Alzheimer's DrugBiogen BIIB and Japan-based partner, Eisai, announced an update regarding the regulatory review of an application seeking the ...
Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...
AstraZeneca (AZN.L, AZN) announced Imfinzi was recommended for approval in the European Union by CHMP as first and only immunotherapy ...
Valneva's Ixchiq vaccine – which was cleared in the EU, the US, and Canada last year – is currently indicated for preventing ...
Johnson & Johnson’s subcutaneous form of Rybrevant has been recommended for approval by the European Medicines Agency’s human ...
Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal ...
The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...
Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback